The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either
The common stock of software developer Cedara could be barred from trading on the Nasdaq exchange unless company officials can convince regulators otherwise. Executives of the Canadian company were notified Jan. 9 that Cedara does not comply with either the net tangible assets or minimum stockholders' equity requirements for continued listing on the exchange. The company intends to request a hearing before a Nasdaq listing qualifications panel to review the decision.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.